Victory Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
19,278
+1,735
+10% +$110K ﹤0.01% 1747
2025
Q4
$1.11M Sell
17,543
-92
-0.5% -$5.72K ﹤0.01% 1785
2025
Q3
$969K Sell
17,635
-20,479
-54% -$844K ﹤0.01% 1855
2025
Q2
$1.26M Buy
38,114
+16,538
+77% +$575K ﹤0.01% 1742
2025
Q1
$867K Sell
21,576
-140
-0.6% -$6.43K ﹤0.01% 1868
2024
Q4
$1.02M Sell
21,716
-13,888
-39% -$721K ﹤0.01% 1801
2024
Q3
$1.88M Sell
35,604
-1,435
-4% -$80K ﹤0.01% 1501
2024
Q2
$2.01M Buy
37,039
+3,436
+10% +$207K ﹤0.01% 1442
2024
Q1
$2.36M Sell
33,603
-158,051
-82% -$12.2M ﹤0.01% 1410
2023
Q4
$16M Buy
191,654
+174,848
+1,040% +$6.33M 0.02% 863
2023
Q3
$495K Buy
16,806
+1,091
+7% +$36.3K ﹤0.01% 1994
2023
Q2
$513K Buy
15,715
+320
+2% +$11.8K ﹤0.01% 1972
2023
Q1
$542K Sell
15,395
-70,037
-82% -$2.86M ﹤0.01% 1972
2022
Q4
$3.91M Sell
85,432
-513,796
-86% -$22.1M ﹤0.01% 1255
2022
Q3
$29M Buy
599,228
+523,279
+689% +$25.2M 0.03% 655
2022
Q2
$2.98M Buy
75,949
+52,886
+229% +$2.13M ﹤0.01% 1361
2022
Q1
$920K Buy
23,063
+14,398
+166% +$512K ﹤0.01% 1850
2021
Q4
$395K Sell
8,665
-1,106
-11% -$42.7K ﹤0.01% 2281
2021
Q3
$349K Buy
+9,771
New +$288K ﹤0.01% 2332
2021
Q2
Sell
-9,933
Closed -$231K 2766
2021
Q1
$231K Buy
+9,933
New +$212K ﹤0.01% 2486
2020
Q2
Sell
-16,170
Closed -$190K 2706
2020
Q1
$190K Buy
16,170
+4,799
+42% +$61.2K ﹤0.01% 2340
2019
Q4
$121K Buy
11,371
+3,057
+37% +$31.4K ﹤0.01% 2480
2019
Q3
$95K Buy
+8,314
New +$104K ﹤0.01% 2454

Other funds holding CYTK